Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00150
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

βKlotho Suppresses Tumor Growth in Hepatocellular Carcinoma by Regulating Akt/GSK-3β/Cyclin D1 Signaling Pathway

PLoS ONE
Multidisciplinary
2013English

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

CXCR7 Correlates With the Differentiation of Hepatocellular Carcinoma and Suppresses HNF4α Expression Through the ERK Pathway

Oncology Reports
MedicineCancer ResearchOncology
2014English

Mannan-Binding Lectin Suppresses Growth of Hepatocellular Carcinoma by Regulating Hepatic Stellate Cell Activation via the ERK/COX-2/PGE2 Pathway

OncoImmunology
OncologyAllergyImmunology
2018English

MicroRNA-302b Suppresses Cell Proliferation by Targeting EGFR in Human Hepatocellular Carcinoma SMMC-7721 Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Regulation of ERK and AKT Pathways by Hepatitis?B Virus?X Protein via the Notch1 Pathway in Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2017English

MicroRNA‑143‑3p Suppresses Cell Growth and Invasion in Laryngeal Squamous Cell Carcinoma via Targeting the K‑Ras/Raf/Mek/Erk Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

MicroRNA-144-3p Suppresses Tumor Growth and Angiogenesis by Targeting SGK3 in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy